Brief: FDA Says BD Expands Class I Voluntary Recall Initiated In U.S. On July 8
Sept 16 (Reuters) - FDA: FDA: BD EXPANDED CLASS I VOLUNTARY RECALL INITIATED IN U.S. ON JULY 8, TO INFORM OF WORST-CASE PERFORMANCE FOR CERTAIN BD ALARIS PUMP INFUSION SETS FDA: CERTAIN BD ALARIS PUMP INFUSION SETS RECALL UPDATE INCLUDES EXPANSION OF 15 ADDITIONAL IMPACTED PUMP INFUSION SETS INCLUDED IN THE RECALL Further company coverage: BDX.N ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Becton Dickinson and
See all newsBrief: Bd Strengthens Leadership In Peripheral Vascular Innovation With Positive Agility Trial Results
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
Becton Dickinson rises after pledging $19 billion US investment for tariff relief
Factbox: Global healthcare companies invest billions to boost US presence
Brief: Becton Dickinson To Invest $19 billion In US